|
|
Product Name |
Composition |
|
| Date |
Product Name |
COMPOSITION |
Ref. |
|
| 1 |
Cefixime, Ofloxacin & Lactic acid |
Each Film Coated Tablet Contains |
|
|
|
Bacillus Tablets |
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
400 mg. |
|
|
Ofloxacin I.P. |
|
200 mg. |
|
|
Lactic acid bacillus |
|
60 million spores |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 2 |
Cefixime, Ofloxacin & Lactic acid |
Each Film Coated Tablet Contains |
|
|
|
Bacillus Tablets |
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
200 mg. |
|
|
Ofloxacin I.P. |
|
400 mg. |
|
|
Lactic acid bacillus |
|
60 million spores |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 4 |
Cefixime & Lactic acid Bacillus |
Each Film Coated Tablet Contains |
|
|
|
Tablets |
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
200 mg. |
|
|
Lactic acid bacillus |
|
60 million spores |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 5 |
Cefixime & Moxifloxacin Tablets |
Each Film Coated Tablet Contains |
|
|
|
|
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
400 mg. |
|
|
Moxifloxacin Hcl I.P. |
|
|
|
|
eq. to Moxifloxacin |
|
400 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 6 |
Cefixime & Cloxacillin (ER) Tablets |
Each Film Coated Tablet Contains |
|
|
|
|
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
400 mg. |
|
|
Cloxacillin Sodium I.P. |
|
|
|
|
eq. To Cloxacillin |
|
500 mg. |
|
|
(as extended Release) |
|
|
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 7 |
Cefixime & Dicloxacillin Tablets |
Each Film Coated Tablet Contains |
|
|
|
|
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
200 mg. |
|
|
Dicloxacillin Sodium I.P. |
|
|
|
|
eq to Dicloxacillin |
|
500 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 8 |
Cefixime Tablets 50 mg. |
Each Uncoated Dispersible Tablet Contains |
|
|
|
|
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
50 mg. |
|
|
Excipients |
|
qs. |
| 9 |
Cefixime Tablets 100 mg. |
Each Film Coated Tablet Contains |
|
|
|
|
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
100 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 10 |
Cefixime Tablets 200 mg. |
Each Film Coated Tablet Contains |
|
|
|
|
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
200 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 12 |
Cefixime & Ofloxacin Tablets |
Each Film Coated Tablet Contains |
|
|
|
|
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
200 mg. |
|
|
Ofloxacin I.P. |
|
200 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 13 |
Cefpodoxime Proxetil |
Each Film Coated Tablet contains |
|
100 mg. |
|
Tablets I.P. 100 mg |
Cefpodoxime Proxetil I.P. |
|
|
|
|
eq. to cefpodoxime (Anhydrous) |
|
|
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 14 |
Cefpodoxime Proxetil |
Each Film Coated Tablet contains |
|
|
|
Tablets I.P. 200 mg |
Cefpodoxime Proxetil I.P. |
|
|
|
|
eq. to cefpodoxime (Anhydrous) |
|
200 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 15 |
Cefpodoxime Proxetil & |
Each Film Coated Tablet contains |
|
|
|
Ofloxacin Tablets |
Cefpodoxime Proxetil I.P. |
|
|
|
|
eq. to cefpodoxime (Anhydrous) |
|
200 mg. |
|
|
Ofloxacin I.P. |
|
200 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 16 |
Cefpodoxime Proxetil, |
Each Film Coated Tablet contains |
|
|
|
Ofloxacin, lactic acid bacillus |
Cefpodoxime Proxetil I.P. |
|
|
|
Tablets |
eq. to cefpodoxime (Anhydrous) |
|
200 mg. |
|
|
Ofloxacin I.P. |
|
200 mg. |
|
|
Lactic acid bacillus |
|
60 million spores |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 17 |
Cefpodoxime dispersible |
Each unCoated Disperseable Tablet contains |
|
|
|
Tablets 50 mg |
Cefpodoxime proxetil I.P. |
|
|
|
|
eq. to cefpodoxime (Anhydrous) |
|
50 mg. |
|
|
Excipients |
|
qs. |
| 18 |
Cefuroxime Axetil Tablets I.P. |
Each film coated tablet Contains |
|
|
|
250 mg. |
Cefuroxime Axetil I.P. |
|
|
|
|
eq. to Cefuroxime |
|
250 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
|
|
Di Oxide I.P. |
|
|
| 19 |
Cefuroxime Axetil Tablets I.P. |
Each film coated tablet Contains |
|
|
|
500 mg. |
Cefuroxime Axetil I.P. |
|
|
|
|
eq. to Cefuroxime |
|
500 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 20 |
Cefpodoxime Proxetil Oral |
Each 5 ml. (After reconstituted suspension) contains |
|
|
|
suspension I.P. |
Cefpodoxime proxetil I.P. |
|
|
|
|
eq. to cefpodoxime (Anhydrous) |
|
50 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 21 |
Cefixime Oral Suspension I.P. |
Each 5 ml. (After reconstituted suspension) contains |
|
|
|
|
Cefixime I.P. |
|
|
|
|
eq. to Cefixime Anhydrous |
|
50 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
|
|
In a flavoured syrupy base |
|
|
| 22 |
Cefixime & Lactic acid Bacillus |
Each unCoated Disperseable Tablet contains |
60 million spores |
|
|
Tablets |
Cefixime (as Trihydrate) I.P. |
|
|
|
|
eq. to Anhydrous Cefixime |
|
200 mg. |
|
|
Lactic acid bacillus |
|
|
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 23 |
Amoxycillin Trihydrate |
Each hard gelatin capsule contains |
|
500 mg. |
|
Capsules I.P. 500 mg. |
Amoxycillin Trihydrate I.P. |
|
|
|
|
eq. to Amoxycillin |
|
|
|
|
Approved colours used in hard gelatin capsule shells |
|
|
| 24 |
Amoxycillin Trihydrate |
Each uncoated Dispersible tablet contains |
|
|
|
Dispersible Tablets I.P. 250 mg. |
Amoxycillin Trihydrate I.P. |
|
|
|
|
eq. to Amoxycillin |
|
250 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 25 |
Amoxycillin Trihydrate |
Each film coated tablet contains |
|
500 mg. |
|
Tablets 500 mg. |
Amoxycillin Trihydrate I.P. |
|
|
|
|
eq. to Amoxycillin |
|
|
|
|
Colour: Approved Colour Used |
|
|
| 26 |
Cefpodoxime Oral suspension |
Each 5 ml. (On reconstituted suspension) contains |
|
|
|
|
Cefpodoxime proxetil I.P. |
|
|
|
|
eq. to cefpodoxime (Anhydrous) |
|
50 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
|
|
In a flavoured syrupy base |
|
|
| 27 |
Cefpodoxime Oral suspension |
Each 5 ml. (On reconstituted suspension) contains |
I.P. |
|
|
|
Cefpodoxime proxetil |
|
|
|
|
eq. to cefpodoxime (Anhydrous) |
|
100 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
|
|
In a flavoured syrupy base |
|
|
| 28 |
Cefdinir Tablets 300 mg. |
Each Film Coated Tablet Contains |
|
|
|
|
Cefdinir USP |
|
300 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 29 |
Cefixime Tablets 50 mg. |
Each Uncoated Dispersible Tablet Contains |
|
|
|
|
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
100 mg. |
|
|
Excipients |
|
qs. |
| 30 |
Cefuroxime Axetil Dispersible |
Each uncoated Disperible tablet Contains |
|
|
|
Tablet I.P. 125 mg. |
Cefuroxime Axetil I.P. |
|
|
|
|
eq. to Cefuroxime |
|
125 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 31 |
Cefpodoxime Proxetil Dispersible |
Each Uncoated Dispersible Tablet contains |
|
|
|
Tablets I.P. 200 mg |
Cefpodoxime Proxetil I.P. |
|
|
|
|
eq. to cefpodoxime (Anhydrous) |
|
200 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 32 |
Cefpodoxime Proxetil Dispersible |
Each Uncoated Dispersible Tablet contains |
|
|
|
Tablets I.P. 100 mg |
Cefpodoxime Proxetil I.P. |
|
|
|
|
eq. to cefpodoxime (Anhydrous) |
|
100 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
| 33 |
Cefixime & Ofloxacin Syrup |
Each 5 ml. after reconstitution contains |
|
|
|
|
Cefixime trihydrate I.P. |
|
|
|
|
eq. to Anhydrous cefixime |
|
100 mg. |
|
|
Ofloxacin I.P. |
|
100 mg. |
|
|
Excipients |
|
qs. |
|
|
Colour: Approved Colour Used |
|
|
